{"id":403075,"date":"2026-04-29T10:13:06","date_gmt":"2026-04-29T10:13:06","guid":{"rendered":"https:\/\/www.newsbeep.com\/nz\/403075\/"},"modified":"2026-04-29T10:13:06","modified_gmt":"2026-04-29T10:13:06","slug":"why-this-asx-healthcare-high-flyer-just-dropped-another-9-today","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/nz\/403075\/","title":{"rendered":"Why this ASX healthcare high-flyer just dropped another 9% today"},"content":{"rendered":"\n

4DMedical Ltd\u00a0(ASX: 4DX<\/a>) shares are falling again on Wednesday, with the high-growth stock extending losses despite no new update.<\/p>\n

At the time of writing, the 4DMedical share price is down a sizeable 9.34% to $4.27. <\/p>\n

That follows a 5.23% drop yesterday and leaves the stock down more than 20% over the past week. <\/p>\n

There has been no announcement to explain the move, which points to broader forces at play.<\/p>\n

Let’s take a closer look.<\/p>\n

\"A<\/p>\n

Image source: Getty Images<\/p>\n

Selling builds after massive run <\/p>\n

The recent pullback comes after an extraordinary run for the stock.<\/p>\n

4DMedical shares are still up more than 1,300% over the past 12 months, even after this week’s decline. The company’s\u00a0market capitalisation<\/a>\u00a0sits around $2.5 billion, and it remains in the\u00a0S&P\/ASX 200 Index\u00a0(ASX: XJO).<\/p>\n

That surge was driven by growing interest in its lung imaging platform, alongside regulatory wins and commercial progress in the United States. <\/p>\n

But when a stock moves that far, that fast, it tends to attract a lot of short-term interest.<\/p>\n

Day traders often pile in during the sharp rally. But when momentum fades, they can exit just as quickly to lock in profits.<\/p>\n

And that can amplify the downside, especially when buying support is limited.<\/p>\n

Tech sector weakness adds pressure <\/p>\n

The broader backdrop is not helping.<\/p>\n

The\u00a0S&P\/ASX All Technology Index\u00a0(ASX: XIJ) is down 4.18% over the past week and has fallen roughly 20% over the past 12 months.<\/p>\n

This shows that the selling is not limited to one stock.<\/p>\n

Growth shares have been under pressure as investors rotate away from higher-valuation companies, which has been noticeable over the last few sessions. <\/p>\n

The\u00a0ASX 200 Index has also been drifting lower. It is down about 2.93% over the past week and is trading around 8,687 points today.<\/p>\n

Valuation and expectations in focus <\/p>\n

4DMedical is still in its growth phase.<\/p>\n

It is building out its commercial footprint and pushing for wider adoption of its imaging technology. That includes contracts, regulatory approvals, and hospital rollouts.<\/p>\n

The trade-off is that earnings remain limited. The company is not profitable yet, and that could take time as it continues to scale.<\/p>\n

That leaves the share price closely tied to future expectations.<\/p>\n

Foolish Takeaway <\/p>\n

This week’s pullback shows how quickly sentiment can shift with high-growth stocks.<\/p>\n

4DMedical has clear potential, and its recent run shows how strong the upside can be. But it is still not profitable, which adds risk at current levels.<\/p>\n

Personally, I would rather back a more established name like\u00a0Pro Medicus Ltd\u00a0(ASX: PME<\/a>), which is already delivering consistent earnings.<\/p>\n

4DMedical may have upside, but it comes with higher\u00a0volatility<\/a>\u00a0and risk.<\/p>\n","protected":false},"excerpt":{"rendered":"4DMedical Ltd\u00a0(ASX: 4DX) shares are falling again on Wednesday, with the high-growth stock extending losses despite no new…\n","protected":false},"author":2,"featured_media":403076,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[134,527,111,139,69],"class_list":["post-403075","post","type-post","status-publish","format-standard","has-post-thumbnail","category-healthcare","tag-health","tag-healthcare","tag-new-zealand","tag-newzealand","tag-nz"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts\/403075","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/comments?post=403075"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts\/403075\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/media\/403076"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/media?parent=403075"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/categories?post=403075"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/tags?post=403075"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}